semaglutide with b12 Semaglutide/B12 Injection Home Kit Telehealth Semaglutide + B12 Injections
Description
Diabetes Care 2010, 33, 428433
L.CaparelliE
Ozempic came out in 2017, and the semaglutide patent is set to expire ~2030
Over a longer 2-year trial, the rate of GI adverse events climbed to 82% on semaglutide (source)
The primary risk of taking expired Rybelsus is therapeutic failure, which may lead to inadequate blood glucose control and increase the risk of diabetes complications including cardiovascular disease, retinopathy, nephropathy, and neuropathy
